vaccine adverse event reporting system


Also found in: Acronyms, Wikipedia.

vaccine adverse event reporting system

,

VAERS

A national surveillance system for monitoring undesirable reactions to administered vaccines.
References in periodicals archive ?
Understanding vaccine safety information from the vaccine adverse event reporting system.
The following adverse events have been identified during post-approval use of RotaTeq from reports to the Vaccine Adverse Event Reporting System (VAERS).
htm, or by mail to Vaccine Adverse Event Reporting System, P.
As of October 2009, the Vaccine Adverse Event Reporting System (VAERS) had received 15,037 reports of adverse reactions, including the development of Guillian-Barre syndrome, lupus, seizures, paralysis, blood clots, brain inflammation, and deaths, according to journalist Susan Brinkmann.
Of the more than 10,300 adverse events reported thus far to the Vaccine Adverse Event Reporting System (VAERS), 94% have been nonserious.
21 /PRNewswire-USNewswire/ -- The National Vaccine Information Center (NVIC) today released a new analysis of the federal Vaccine Adverse Event Reporting System (VAERS) reports of serious health problems following HPV vaccination (Merck's GARDASIL) during the last six months of 2006.
A review of reports submitted to the Vaccine Adverse Event Reporting System (VAERS) in the United States from 1990 to 1997 found a rate of probable anaphylaxis after YF vaccine immunization of 1 per 131,000 vaccine doses distributed (13).
In an analysis of reports made to the federal Vaccine Adverse Event Reporting System (VAERS) since the CDC's July 2006 universal use recommendation for all young girls, NVIC found reports of loss of consciousness, seizures, joint pain and Guillain-Barre Syndrome.
of the CDC's Immunization Safety Office, said that only 39 reports had been received by the Vaccine Adverse Event Reporting System.
of the CDC's Immunization Safety Office, noted that only 39 reports had been received by the Vaccine Adverse Event Reporting System.
However, since RotaTeq has been on the market, cases of intussusception in infants who received RotaTeq have been reported to the Vaccine Adverse Event Reporting System (VAERS).
Any physician with a patient who develops Guillain-Barre syndrome after receiving the meningococcal conjugate vaccine should report the case to the Vaccine Adverse Event Reporting System, according to an alert issued by the Food and Drug Administration and the Centers for Disease Control and Prevention.